---
title: "Why This Top-Notch Trio Of Biotech Stocks Just Took A Tumble"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294713077.md"
description: "Leading biotech companies TG Therapeutics and Twist Bioscience experienced significant declines on Monday following the release of their second-quarter reports. The stocks of these top-performing companies dropped due to mixed results. The sudden fall in value has raised concerns among investors, as these companies were previously considered top-notch in the biotech sector."
datetime: "2026-08-03T15:02:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294713077.md)
  - [en](https://longbridge.com/en/news/294713077.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294713077.md)
generator: "portal-rs"
---

# Why This Top-Notch Trio Of Biotech Stocks Just Took A Tumble

Leading biotech companies TG Therapeutics and Twist Bioscience experienced significant declines on Monday following the release of their second-quarter reports. The stocks of these top-performing companies dropped due to mixed results. The sudden fall in value has raised concerns among investors, as these companies were previously considered top-notch in the biotech sector.

### Related Stocks

- [TGTX.US](https://longbridge.com/en/quote/TGTX.US.md)
- [TWST.US](https://longbridge.com/en/quote/TWST.US.md)

## Related News & Research

- [Insider Decision: Laurence N Charney Offloads $274K Worth Of TG Therapeutics Stock](https://longbridge.com/en/news/299069037.md)
- [Twist Bioscience (TWST) Stock Looks Undervalued On Cash Flow But Overvalued On Sales](https://longbridge.com/en/news/298517695.md)
- [TG Therapeutics director Laurence N. Charney disposes of 5,000 common shares worth $274,800](https://longbridge.com/en/news/298962383.md)
- [TG Therapeutics CEO Weiss to join H.C. Wainwright Global Investment Conference fireside chat](https://longbridge.com/en/news/298589235.md)
- [Active Biotech AB (publ) (STO:ACTI): Is Breakeven Near?](https://longbridge.com/en/news/298678959.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**